[Serum lipoproteins and antilipemic drugs related to clofibrate. Their in vitro interaction].
D000362:Agar; D000818:Animals; D002482:Cellulose; D055598:Chemical Phenomena; D002621:Chemistry; D002914:Chylomicrons / Q000097:blood; D002994:Clofibrate / Q000378:metabolism / Q000494:pharmacology*; D006224:Cricetinae; D003956:Dialysis; D004586:Electrophoresis; D006801:Humans; D000960:Hypolipidemic Agents / Q000378:metabolism / Q000494:pharmacology*; D007122:Immunoelectrophoresis; D007074:Immunoglobulin G; D066298:In Vitro Techniques; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000096:biosynthesis / Q000097:blood*; D008077:Lipoproteins, LDL / Q000032:analysis; D008079:Lipoproteins, VLDL / Q000032:analysis; D010743:Phospholipids / Q000097:blood; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D012709:Serum Albumin / Q000378:metabolism
D002914:Chylomicrons; D000960:Hypolipidemic Agents; D007074:Immunoglobulin G; D008055:Lipids; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010743:Phospholipids; D012709:Serum Albumin; D000362:Agar; D002482:Cellulose; D002994:Clofibrate
Lipoprotéines du sérum et médicaments hypolipidémiants apparentés au clofibrate. Leur interaction in vitro.